|
Re: Try this one
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 21, 2020 12:18PM
|
|
Re: Drug: RVX000222 100 mg capsule Other Name: apabetalone
|
3
|
Resverlogix Corp.
|
Feb 21, 2019 10:32AM
|
|
Re: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
|
3
|
Resverlogix Corp.
|
Aug 14, 2019 02:29PM
|
|
Re: Thoughts on the election....
|
3
|
Resverlogix Corp.
|
Nov 03, 2016 05:17PM
|
|
Resverlogix Supports Epigenetics Satellite Symposium and Provides Oral Presentation on Apabetalone at the European Society of Cardiology Congress 2018
|
3
|
Resverlogix Corp.
|
Aug 22, 2018 07:08AM
|
|
Re: New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
3
|
Resverlogix Corp.
|
May 12, 2016 10:00AM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
3
|
Zenith Epigenetics
|
Jun 16, 2016 09:24AM
|
|
Re: Reata, Friedreich’s Ataxia and Kidney Disease
|
3
|
Resverlogix Corp.
|
Oct 18, 2019 06:58AM
|
|
Re: A fair and optimistic write up on BETonMACE
|
3
|
Resverlogix Corp.
|
Nov 24, 2019 07:31PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
3
|
Resverlogix Corp.
|
Dec 01, 2018 03:27PM
|
|
Re: Resverlogix presentation at European Meeting on Complement in Human Disease meeting
|
3
|
Resverlogix Corp.
|
Sep 08, 2017 05:10PM
|
|
Re: Zenith Epigenetics Announces Clinical Collaboration with Astellas
|
3
|
Zenith Epigenetics
|
Apr 22, 2021 04:34PM
|
|
Re: Spike
|
3
|
Resverlogix Corp.
|
Sep 08, 2018 08:59PM
|
|
Re: Consequences of BETonMACE Findings
|
3
|
Resverlogix Corp.
|
May 10, 2016 04:26PM
|
|
Re: Timelines for notice of meeting for AGMs
|
3
|
Resverlogix Corp.
|
Sep 14, 2016 04:36PM
|
|
Re: ...new publication just tweeted out> ... link
|
3
|
Resverlogix Corp.
|
Jan 09, 2018 04:51PM
|
|
Re: Zenith Announces Initiation of Phase 1b ZEN-3694 Trial
|
3
|
Zenith Epigenetics
|
Dec 14, 2016 11:40AM
|
|
Not even on the radar in this "state of the art" review
|
3
|
Resverlogix Corp.
|
Jun 20, 2018 11:52AM
|
|
Re: Tick tock
|
3
|
Resverlogix Corp.
|
Aug 11, 2017 03:42PM
|
|
Re: Last hour.....
|
3
|
Resverlogix Corp.
|
May 31, 2019 09:32PM
|
